Pacer Advisors Inc. Purchases Shares of 21,370 Option Care Health, Inc. $OPCH

Pacer Advisors Inc. acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,370 shares of the company’s stock, valued at approximately $593,000.

Other large investors have also modified their holdings of the company. Durable Capital Partners LP raised its holdings in Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the period. Arrowstreet Capital Limited Partnership grew its position in shares of Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after purchasing an additional 1,778,279 shares during the last quarter. Norges Bank acquired a new stake in shares of Option Care Health in the second quarter valued at about $69,932,000. Jennison Associates LLC increased its stake in shares of Option Care Health by 145.6% in the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after purchasing an additional 1,267,660 shares during the period. Finally, Swedbank AB acquired a new position in shares of Option Care Health during the 3rd quarter worth about $49,455,000. 98.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.64% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on OPCH shares. Cowen began coverage on Option Care Health in a report on Thursday, October 2nd. They issued a “hold” rating on the stock. Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Finally, Morgan Stanley initiated coverage on shares of Option Care Health in a report on Friday, October 17th. They set an “overweight” rating and a $35.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $36.27.

Option Care Health Stock Up 1.2%

Shares of OPCH stock opened at $32.24 on Friday. Option Care Health, Inc. has a one year low of $22.62 and a one year high of $35.53. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. The stock has a fifty day moving average price of $30.23 and a 200 day moving average price of $29.39. The stock has a market cap of $5.12 billion, a P/E ratio of 25.59, a price-to-earnings-growth ratio of 2.01 and a beta of 0.80.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.